Search

Fred T Oakes

from Severna Park, MD
Age ~72

Fred Oakes Phones & Addresses

  • 10 Saint Andrews Crossover, Severna Park, MD 21146 (410) 729-8450
  • 503 Old Pasture Ln, Severna Park, MD 21146 (410) 647-7584
  • Annapolis, MD
  • Downingtown, PA
  • 342 Long Ridge Ln, Exton, PA 19341 (610) 594-7814
  • 24 Oak Hill Cir, Malvern, PA 19355 (610) 644-3789
  • 600 Swedesford Rd, Malvern, PA 19355 (610) 647-3818
  • Chester, PA

Work

Company: Luxxur 1995 to 2007 Position: President

Education

Degree: Post Doc School / High School: University of Illinois at Urbana-Champaign 1981 to 1985 Specialities: BioOrganic Chemistry

Skills

HPLC

Industries

Biotechnology

Public records

Vehicle Records

Fred Oakes

View page
Address:
10 Saint Andrews Crossover, Severna Park, MD 21146
Phone:
(410) 729-8450
VIN:
1HGCM66537A081606
Make:
HONDA
Model:
ACCORD
Year:
2007

Resumes

Resumes

Fred Oakes Photo 1

Independent Biotechnology Professional

View page
Location:
Baltimore, Maryland Area
Industry:
Biotechnology
Work:
LUXXUR 1995 - 2007
President

Apollon, inc. 1992 - 1995
assoc dir

eastman kodak life sciences div 1985 - 1992
research scientist

eastman kodak 1985 - 1992
research scientist
Education:
University of Illinois at Urbana-Champaign 1981 - 1985
Post Doc, BioOrganic Chemistry
Miami University 1976 - 1981
Ph.D., Organic Chemistry
The Ohio State University 1970 - 1976
b.s., chemistry
Skills:
HPLC

Publications

Us Patents

Nuclease Resistant Compounds

View page
US Patent:
55678106, Oct 22, 1996
Filed:
May 31, 1995
Appl. No.:
8/456017
Inventors:
Alexander L. Weis - Berwyn PA
Fred T. Oakes - Rochester NY
Frederick H. Hausheer - San Antonio TX
Paul F. Cavanaugh - West Chester PA
Patricia S. Moskwa - Phoenixville PA
Assignee:
Sterling Drug, Inc. - New York NY
International Classification:
C07H 2100
A61K 31045
A61K 31715
C07C 3120
US Classification:
536 253
Abstract:
Compounds, compositions and methods for inhibiting gene expression are disclosed. The compounds comprise oligonucleotide sequences of from about 9 to about 200 bases having a diol at either or both termini. Preferred diols are polyalkyleneglycols, preferably polyethyleneglycols. Pharmaceutical compositions comprising the compounds and a physiologically acceptable carrier and methods of inhibiting gene expression in mammals comprising administering such compounds are also provided. Methods for inhibiting nuclease cleavage of compounds are also provided.

Ribozymes With Linked Anchor Sequences

View page
US Patent:
60808519, Jun 27, 2000
Filed:
Jul 10, 1995
Appl. No.:
8/448446
Inventors:
Catherine J. Pachuk - Lansdowne PA
Leslie R. Coney - Rosemont PA
Fred T. Oakes - Malvern PA
Assignee:
American Home Products Corporation - Madison NJ
International Classification:
C12Q 168
C07H 2104
US Classification:
536 245
Abstract:
Ribozymes are provided in which the ribozymes have a catalytic sequence, two legs and at least one anchor sequence complementary to the substrate mRNA at a location noncontiguous with the portions of the substrate mRNA complementary to the legs. In certain preferred embodiments, ribozymes capable of cleaving the L6 mRNA or both the L6 and K28 mRNAs are provided. Methods are provided for the treatment of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL) patients having the L6 and K28 translocations and, therefore, the L6 mRNA. Additionally, combination treatments comprising components specific for both the K28 and L6 mRNAs are provided. Combination treatments are also provided for those patients which express c-myc in combination with K28 and/or L6 mRNAs. Methods of treatment include, for example, administration of ribozymes and antisense oligonucleotides directed against these mRNAs.

Oligonucleotide Analogues Containing Phosphate Diester Linkage Substitutes, Compositions Thereof, And Precursor Dinucleotide Analogues

View page
US Patent:
56774397, Oct 14, 1997
Filed:
May 24, 1995
Appl. No.:
8/449124
Inventors:
Alexander Ludvik Weis - Berwyn PA
Frederick Herman Hausheer - San Antonio TX
Prasad Venkata Chala Chaturvedula - Exton PA
Daniel Joseph Delecki - Radnor PA
Paul Francis Cavanaugh - West Chester PA
Patricia Susan Moskwa - Phoenixville PA
Fred Terry Oakes - Rochester NY
Assignee:
Sanofi - Paris
International Classification:
C07H 2104
US Classification:
536 231
Abstract:
The present invention relates to compounds, compositions and methods for inhibiting gene expression. The compounds of this invention comprise 1) oligonucleoside sequences of from about 6 to about 200 bases having a three atom internucleoside linkage or 2) oligonucleotide sequences of from about 9 to about 200 bases having a diol at either or both termini.

Exonuclease Resistant Terminally Substituted Oligonucleotides

View page
US Patent:
52450228, Sep 14, 1993
Filed:
Aug 3, 1990
Appl. No.:
7/562180
Inventors:
Alexander L. Weis - Berwyn PA
Fred T. Oakes - Rochester NY
Frederick H. Hausheer - San Antonio TX
Paul F. Cavanaugh - West Chester PA
Patricia S. Moskwa - Phoenixville PA
Assignee:
Sterling Drug, Inc. - New York NY
International Classification:
C07H 2100
US Classification:
536 245
Abstract:
Compounds, compositions and methods for inhibiting gene expression are disclosed. The compounds comprise oligonucleotide sequences of from about 9 to about 200 bases having a diol at either or both termini. Preferred diols are polyalkyleneglycols, preferably polyethyleneglycols. Pharmaceutical compositions comprising the compounds and a physiologically acceptable carrier and methods of inhibiting gene expression in mammals comprising administering such compounds are also provided. Methods for inhibiting nuclease cleavage of compounds are also provided.
Fred T Oakes from Severna Park, MD, age ~72 Get Report